tiprankstipranks
Nuvalent (NUVL)
NASDAQ:NUVL
US Market
NUVL
Nuvalent
RESEARCH TOOLSreports
Want to see NUVL full AI Analyst Report?

Nuvalent (NUVL) Stock News & Sentiment

182 Followers
Nuvalent Buy Rating: Zidesamtinib’s Differentiated ROS1 CNS Efficacy Supports $155 Target Price
Premium
Ratings
Nuvalent Buy Rating: Zidesamtinib’s Differentiated ROS1 CNS Efficacy Supports $155 Target Price
15d ago
NUVL
Nuvalent: Buy Rating on Strong Pipeline Execution, Dual NDA Momentum, and Solid Cash Runway in Targeted NSCLC
Premium
Ratings
Nuvalent: Buy Rating on Strong Pipeline Execution, Dual NDA Momentum, and Solid Cash Runway in Targeted NSCLC
29d ago
NUVL
Nuvalent Files FDA Application for Lung Cancer Therapy
Premium
Company Announcements
Nuvalent Files FDA Application for Lung Cancer Therapy
29d ago
8K
NUVL
De-Risked Oncology Pipeline and Strong Cash Position Underpin Outperform Rating and $125 Target
Premium
Ratings
De-Risked Oncology Pipeline and Strong Cash Position Underpin Outperform Rating and $125 Target
2M ago
NUVL
Nuvalent: Buy Rating Backed by Late‑Stage Oncology Pipeline and Upcoming Value‑Driving Milestones
Premium
Ratings
Nuvalent: Buy Rating Backed by Late‑Stage Oncology Pipeline and Upcoming Value‑Driving Milestones
2M ago
NUVL
3 ‘Strong Buy’ Stocks to Buy Today, 12/18/2025, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Stocks to Buy Today, 12/18/2025, According to Top Analysts
5M ago
FHTX
NUVL
Nuvalent’s Royalty Interest Acquired by Royalty Pharma
Premium
Company Announcements
Nuvalent’s Royalty Interest Acquired by Royalty Pharma
5M ago
8K
NUVL
More NUVL News >

NUVL News on the Web

Nuvalent to present preclinical data for zidesamtinib at AACR meeting
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Nuvalent (NUVL) and Innoviva (INVA)
TipRanks News
Neutral
Nuvalent: Buy Rating on Strong Pipeline Execution, Dual NDA Momentum, and Solid Cash Runway in Targeted NSCLC
TipRanks News
Bullish
Nuvalent Announces NDA Submission For Neladalkib
rttnews
Bullish
Nuvalent Files FDA Application for Lung Cancer Therapy
TipRanks News
Neutral
Nuvalent submits neladalkib NDA to FDA
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Privia Health Group (PRVA), Nuvalent (NUVL) and Tonix Pharma (TNXP)
TipRanks News
Bullish
Nuvalent (NUVL) Receives a Buy from Stifel Nicolaus
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
NUVL
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.75 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NUVL’s Media Buzz Sentiment?
1 articles about NUVL were published this week. In an average week, 2.75 articles are published.
    What is NUVL’s weekly average amount of articles?
    In an average week, 2.75 articles about NUVL are published.
      What is NUVL’s News Sentiment?
      100% of articles about NUVL were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week